ArticleMolecular cancer research : MCR2019

Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.

Erika S Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.